Preventive but Not Curative Efficacy of Celecoxib on Bladder Carcinogenesis in a Rat Model
2010

Celecoxib's Role in Preventing Bladder Cancer in Rats

Sample size: 52 publication 10 minutes Evidence: high

Author Information

Author(s): José Sereno, Belmiro Parada, Flávio Reis, Cunha Fernanda X., Teixeira-Lemos Edite, Garrido Patrícia, Pinto Rui, Rocha-Pereira Petronila, Neto Paula, Ruivo José, Rodrigues-Santos Paulo, Nunes Sara, Mota Alfredo, Figueiredo Arnaldo, Teixeira Frederico

Primary Institution: Institute of Pharmacology & Experimental Therapeutics, Coimbra University

Hypothesis

Does celecoxib effectively prevent bladder cancer in a rat model when used preventively compared to curatively?

Conclusion

Preventive treatment with celecoxib significantly inhibits bladder cancer development, while curative treatment worsens tumor malignancy.

Supporting Evidence

  • Preventive celecoxib treatment resulted in only 12.5% tumor incidence compared to 65% in the carcinogen group.
  • The mean tumor volume in the preventive group was significantly lower at 5.3 mm3 compared to 112.5 mm3 in the carcinogen group.
  • Curative treatment with celecoxib led to a 75% tumor incidence and increased tumor malignancy.
  • Serum CRP levels were significantly lower in the celecoxib groups compared to the carcinogen group.
  • Preventive treatment reduced hyperplasia and dysplasia incidence from 100% to 12.5%.

Takeaway

Giving celecoxib before cancer starts helps stop bladder cancer, but giving it after cancer has started can make it worse.

Methodology

The study used 52 male Wistar rats divided into five groups to evaluate the effects of celecoxib on bladder cancer.

Potential Biases

Potential bias in treatment administration and evaluation due to lack of blinding in some analyses.

Limitations

The study was conducted on a rat model, which may not fully replicate human bladder cancer.

Participant Demographics

52 male Wistar rats, aged 250-285g.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2010/380937

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication